Founded
KANDO id: 346491

Corporate information

Registration country

Company type

Builds the first platform for generating human monoclonal antibodies using a transgenic rat.

Funding rounds


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials